Navigation Links
March of Dimes funds new preterm birth research
Date:3/4/2013

ing for his work has been renewed to allow him to build on his past discoveries with the goal of improving health care providers' ability to predict which women are at high risk of delivering their baby too soon.

Other new grant recipients are:

  • Louis Ragolia, PhD, director of Biomedical Research, Winthrop University Hospital, Mineola New York, who is focusing on prostaglandins, specialized lipids that mediate inflammation and play an important role in triggering labor at term, to identify women at risk of infection-related preterm delivery and develop drug treatment to prevent it.

  • Indira U. Mysorekar, PhD, Washington University School of Medicine; St. Louis, Missouri, who is working to identify how bacteria and other infection-causing microorganisms attack the placenta and contribute to preterm birth.

  • Francesco J. DeMayo, PhD, Baylor College of Medicine, Texas, who is seeking to understand the role progesterone plays in suppressing contractions until term. The hormone has been shown to prevent premature delivery among about one-third of women with a singleton pregnancy.

  • Ruth Ann Word, MD, University of Texas Southwestern Medical Center, Dallas, is investigating the role of the protein fetal fibronectin in causing preterm premature rupture of the membranes (PPROM), which is associated with 30 to 40 percent of preterm deliveries in the U.S

In 2013, the March of Dimes celebrates its 75th Anniversary and its ongoing work to help babies get a healthy start in life. Early research led to the Salk and Sabin polio vaccines that all babies still receive. Other breakthroughs include new treatments for premature infants and children with birth defects. About 4 million babies are born each year in the United States, and all have benefitted the March of Dimes life saving research and education.


'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. March story tips
2. March of the pathogens: Parasite metabolism can foretell disease ranges under climate change
3. Southern insect scientists to meet in Baton Rouge in March
4. As climate warms, bark beetles march on high-elevation forests
5. March of Dimes awards $250,000 prize to 2 scientists who pioneered advances in skin disorders
6. UTMB scientist awarded $150,000 by March of Dimes
7. AGU journal highlights for March 29, 2012
8. Story tips From the Department of Energys Oak Ridge National Laboratory, March 2012
9. NIH funds research to identify Parkinsons biomarkers
10. NIH grant funds Boston College research into illnesses afflicting people living with HIV
11. Energy Deptartment funds UW project to turn wasted natural gas into diesel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... plate may soon take on a literal meaning. Diane Bisson, ... Design, has fashioned edible plates that are practical, stylish and ... which has resulted in a book highlighting more than 50 ... Material. "The idea of using food to support a ...
... of Georgia scientists looking to understand the genetic mechanisms ... first time in plants an inverse relationship between gene ... diversity not only in plants, but in animals and ... this week,s Proceedings of the National Academy of ...
... , , TORONTO, Dec. 7 ... acquired the assets of the healthcare communications company previously operating ... now move forward under new leadership and funding. , IgeaCare ... of Chief Executive Officer. Under his direction, the new company ...
Cached Biology News:Plate-eating good: Université de Montréal professor designs edible tableware 2Study finds new relationship between gene duplication and alternative splicing in plants 2Study finds new relationship between gene duplication and alternative splicing in plants 3IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2
(Date:5/21/2015)... -- Prima Biomed Ltd. (NASDAQ: PBMD ) a globally ... leader in the development of immunotherapeutic products for the ... data from the Phase II CAN-003 ovarian cancer clinical ... meaningful improvement in Overall Survival ("OS") over standard of ... the group of second remission patients (n=20), the median ...
(Date:5/21/2015)... 2015 W. R. Grace & ... in Worms, Germany has received good manufacturing practice ... the International Pharmaceutical Excipient Council (IPEC) Foundation. ... its SYLOID® FP brand of pharmaceutical grade excipient ... the Curtis Bay, Maryland (USA) and Sorocaba, Brazil ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
(Date:5/20/2015)... Calif. , May 20, 2015 ... today presented preliminary data demonstrating the ability of ... pulmonary fibrosis (IPF) from other interstitial lung diseases ... suggest the classifier,s potential to help thousands of ... resolve ambiguity in IPF diagnosis – a frequent ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Global Survey on Flow Cytometry Adoption Trends 2015 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5
... - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ... today announced the filing of its audited,consolidated financial ... ended December 31, 2007 and the restatement of ... December 31, 2006., For the year ended ...
... Calif., March 13 Bionovo, Inc.,(Nasdaq: BNVI ... Ph.D., to,the company,s Board of Directors. Dr. Butler ... and in particular in,advancing cancer drug development and ... have George on board as we move into ...
... LEUVEN, Belgium, March 13 ThromboGenics NV,(Euronext Brussels: ... announces a business update and its financial results ... During this period,ThromboGenics has raised additional funds to ... make good progress with its clinical,programs., Highlights, ...
Cached Biology Technology:Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 2Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 3Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 4Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 5Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 6Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 7Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 8Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 9George Butler Joins Bionovo's Board of Directors 2George Butler Joins Bionovo's Board of Directors 3ThromboGenics Announces 2007 Full Year Results 2ThromboGenics Announces 2007 Full Year Results 3ThromboGenics Announces 2007 Full Year Results 4
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
... kit for 25 chips provides the chips ... analysis (at picogram levels) with the Experion ... RNA HighSens microfluidic chips, 2 x 1,250 ... RNA HighSens stain, 20 microliters RNA ladder, ...
Monoclonal Anti-Cystatin A tissue culture supernatant Solution containing 15 mM sodium azide human cystatin A ...
... kit provides all the accessories necessary for ... conformation polymorphism analysis (SSCP) with the DCode ... a cooling finger adaptor for use with ... of 20 cm plates, 2 sets of ...
Biology Products: